Liquichek 111
Liquichek 111 is a Class II device made by Bio-Rad Laboratories, cleared under FDA 510(k) K024229 on 15 Jan 2003 and listed in FDA GUDID since 12 Sep 2016 (UDI-DI 00847661000105), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00847661000105 | Date12 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE | NumberK024229 | Date15 Jan 2003 | StatusActive |
Official records
- AccessGUDID record 00847661000105
- FDA 510(k) database K024229
Across registries
- FDA 510(k) K024229 decided 15 Jan 2003 Active
- FDA GUDID UDI-DI 00847661000105 listed 12 Sep 2016 Listed
Timeline
- Cleared FDA 510(k) K024229
- Listed FDA GUDID 00847661000105
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Liquichek
- Generic name
- Multiple antinuclear antibody (ANA) IVD, control
- Model / Ref / Catalog
- 111
- Primary DI / UDI-DI
- 00847661000105
- 510(k) Number
- FDA product code
- DHN
- GMDN term
- Multiple antinuclear antibody (ANA) IVD, control
- Device class
- Class II
- Regulation number
- 866.5100
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DHN (ANTINUCLEAR ANTIBODY, INDIRECT IMMUNOFLUORESCENT, ANTIGEN, CONTROL).
- ANTI-NUCLEAR ANTIBODY TEST KIT (ANA) by Amico Lab, Inc.
- ANA HEP-2 FLUORO-KIT by Clinical Sciences, Inc.
- LIQUICHEK ANA CONTROL, CENTROMERE PATTERN, MODEL 203 by Bio-Rad
- BION ANTINUCLEAR ANTIBODY(ANA)TEST KIT/CONTR SERUM by Bion Ent., Ltd.
- AUTOFLOUR III SYSTEM by Tech America Diagnostics
- QUANTAFLUOR FLUORESCENT TEST REAGENTS by Kallestad Laboratories, Inc.
- HEMAGEN ENA DSDNA KIT (EIA METHOD) by HEMAGEN DIAGNOSTICS, INC.
- ImmuGlo HEp-2 Elite IFA by Immco Diagnostics, Inc.
- CRITHIDNA ANTI-DNA TEST KIT by Antibodies, Inc.
- HEP-2 ANTINUCLEAR ANTIBODY TEST SYSTEM by Tissue Culture Biotec, Inc.